Dr. Turja Chakrabarti, MD

Dr. Chakrabarti practices at Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare.

Dr. Chakrabarti's NPI, 1659805547, was assigned on April 18, 2017. Dr. Chakrabarti graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2017. Dr. Chakrabarti holds California license A172493.

Dr. Chakrabarti's primary practice is Desert Regional Medical Center, at 1150 North Indian Canyon Drive, Palm Springs, CA 92262 in Riverside County. The practice phone is (760) 323-6511.

Dr. Chakrabarti's primary practice is Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare. Dr. Chakrabarti is also affiliated with Johns Hopkins Bayview Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Chakrabarti to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chakrabarti practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Chakrabarti's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Chakrabarti is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chakrabarti's licenses on file in 2 states: California and Maryland.

Dmand AI lists circulatory problems in extremities, electrolyte disorders, lung disease: COPD, asthma or bronchitis and sepsis among the conditions Dr. Chakrabarti treats.

CMS data shows 119 Medicare services from Dr. Chakrabarti across 1 procedure code in 2024, for 51 Medicare patients. Medicare paid $12,033 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 51 Medicare patients who saw Dr. Chakrabarti in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chakrabarti's median patient age at 67, with 66% women.

In 2024, Dr. Chakrabarti wrote 28 Medicare Part D claims for 17 patients. 93% of them were for generic drugs. They cover 2 drugs, with $548 in total drug cost. In 2021, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chakrabarti for performance year 2024, reported as part of a group.

Dmand AI links 5 papers to Dr. Chakrabarti, published from 2021 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and ErbB Receptors. Dr. Chakrabarti's most frequent co-authors are Collin M. Blakely, MD, Trever Bivona, MD, PhD and Jonathan Wesley Riess, MD, MS.

CMS Open Payments shows 10 general payments to Dr. Chakrabarti from 2 drug and device companies in 2025. Consulting fees make up the largest share, 79% of the total. Janssen Pharmaceuticals, Inc paid the most, $6,001.

Dr. Chakrabarti graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2017.

Dr. Chakrabarti is in network with 5 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.